Carol Ashe
DirectoratElicio Therapeutics· In proxies 2023–2025
Carol Ashe sits on 2 public boards.
Boards1
- Elicio TherapeuticsDirector · 2 yr on the boardIndependentAudit, Compensation (Chair), Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Elicio TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -78%
- Aptose BiosciencesPublic company · 7 yr
- Director2018 – 2025 · 7 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?